T2加权MRI纹理分析预测头颈部副神经节瘤SDH突变
回顾性纳入21例患者共24个头颈部副神经节瘤(14个SDH突变阳性),计算T2加权及增强T1加权MRI的2D纹理特征DNN、SDHGLE、SDLGLE。仅T2基于的SDLGLE有统计学意义(p=0.048),AUROC 0.71,诊断准确率70.8%,作者认为该无创技术可能有助于进一步基因检查。
要点
- T2基于的SDLGLE纹理参数与SDH突变状态相关,AUROC 0.71。
- 其余纹理特征(DNN、SDHGLE)及增强T1基于纹理未达统计学显著。
- 诊断准确率70.8%,仅基于24个病灶的小样本回顾性结果。
核心结论
- T2基于的2D纹理参数SDLGLE可预测头颈部副神经节瘤的SDH突变,该无创技术可能有助于进一步基因检查。
研究设计与样本
- 回顾性研究纳入21例患者(每人1至4个肿瘤)共24个经病理证实的头颈部副神经节瘤,其中14个(58%)为SDH突变阳性。
- 所有患者均行T2加权及增强T1加权MRI序列,计算DNN、SDHGLE、SDLGLE三个2D纹理特征。
- SDH突变组与非突变组纹理比较采用Mann-Whitney U检验,以AUROC量化各纹理的预测能力。
诊断标准与关键数值
- 仅T2基于的SDLGLE有统计学意义(p=0.048),AUROC为0.71,诊断准确率70.8%。
临床应用与阅片要点
- 作者认为T2基于SDLGLE纹理分析可能有助于筛选需进一步基因检查的头颈部副神经节瘤患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Texture analysis can quantify sophisticated imaging characteristics. We hypothesized that 2D textures computed with T2-weighted and post-contrast T1-weighted MRI can predict succinate dehydrogenase (SDH) mutation status in head and neck paragangliomas.
METHODS: Our retrospective study included 21 patients (1 to 4 tumors/patient) with 24 pathologically proven paragangliomas in the head and neck. Fourteen lesions (58%) were SDH mutation-positive. All patients underwent T2-weighted and post-contrast T1-weighted MRI sequences. Three 2D texture features of dependence non-uniformity normalized (DNN), small dependence high gray level emphasis (SDHGLE), and small dependence low gray level emphasis (SDLGLE) were calculated. Computed textures between SDH mutants and non-mutants were compared using Mann-Whitney U test. Area under the receiver operating characteristic (AUROC) curve was used to quantify the predictive power of each texture.
RESULTS: Only T2-based SDLGLE was statistically significant (p = 0.048), and AUROC was 0.71. Diagnostic accuracy was 70.8%.
CONCLUSION: 2D texture parameter of T2-based SDLGLE predicts SDH mutation in head and neck paragangliomas. This noninvasive technique can potentially facilitate further genetic workup.
引用
- Naganawa S, Kim J, Yip SSF, et al. Texture analysis of T2-weighted MRI predicts SDH mutation in paraganglioma. Neuroradiology. 2020. PMID: 33215243. doi:10.1007/s00234-020-02607-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。